Table 3. miR-21 expression and efficacy data in all registered patients.

	Number of events	Number of subjects	Median Survival (Months) (95% CI)	1 Year Survival (95% CI)	Hazard Ratio (95% CI)	p-value
(PFS) Low miR-21 High miR-21	6 6	6 6	12.7 (6.9 – 18.4) 3.5 (2.8 – 4.3)	66.7 (29.1 – 100) 16.7 (0 – 46.5)	1.0 4.7 (1.1 – 19.7)	0.032
(OS) Low miR-21 High miR-21	6 5	6 6	15.3 (7.3 – 23.3) 5.1 (0 – 10.7)	83.3 (53.5 – 100) 33.3 (0 – 70.9)	1.0 1.46 (0.41 – 5.21)	0.564